All Stories

  1. Identification of hsa_circ_0005654 as a new early biomarker of gastric cancer
  2. Using tRNA halves as novel biomarkers for the diagnosis of gastric cancer
  3. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker
  4. Identification and functional annotation of metabolism-associated lncRNAs and their related protein-coding genes in gastric cancer
  5. Circular RNAs in hepatocellular carcinoma: Functions and implications
  6. Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer
  7. Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values
  8. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection
  9. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers
  10. Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances
  11. Global circular RNA expression profile of human gastric cancer and its clinical significance
  12. Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer
  13. Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma
  14. Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances
  15. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma
  16. Circular RNAs: Biogenesis, properties, roles, and their relationships with liver diseases
  17. Plasma lncRNA‑GACAT2 is a valuable marker for the screening of gastric cancer
  18. Roles of long noncoding RNAs in gastric cancer and their clinical applications
  19. Neuropeptide Y Y1 receptors mediate targeted delivery nanoparticles for breast cancer therapy
  20. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression
  21. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer
  22. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance
  23. The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses
  24. Using circular RNA as a novel type of biomarker in the screening of gastric cancer
  25. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
  26. Lycium Barbarum and Tumors in the Gastrointestinal Tract
  27. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer
  28. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer
  29. Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
  30. miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma
  31. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer
  32. miR-129-1-3p Promote BGC-823 Cell Proliferation by Targeting PDCD2
  33. Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively
  34. miR-129-1-3p inhibits cell migration by targeting BDKRB2 in gastric cancer
  35. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer
  36. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis
  37. Clinical significance of the low expression of FER1L4 in gastric cancer patients
  38. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances
  39. Significance of estrogen receptor subtypes in breast tumorigenesis and progression
  40. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance
  41. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance
  42. Growth inhibitory effects of three miR-129 family members on gastric cancer
  43. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association
  44. Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1
  45. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance
  46. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer
  47. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer
  48. Gastric juice miR-129 as a potential biomarker for screening gastric cancer
  49. Antisense Long Non-Coding RNA in the Regulation of Gene Expression
  50. RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties
  51. Long non-coding RNA expression profile in human gastric cancer and its clinical significances
  52. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer
  53. Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance
  54. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients
  55. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells
  56. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients
  57. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin
  58. Research on Toxicity of Medical Metal and Metallic Oxides Nanomaterials
  59. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers
  60. Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells
  61. Integration of Biochemistry and Molecular Biology as a System Curriculum in Chinese Medical Undergraduates
  62. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism
  63. Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells
  64. Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest
  65. Increased expression of miR-421 in human gastric carcinoma and its clinical association
  66. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide
  67. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli
  68. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance
  69. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues
  70. Detection of miR-106a in gastric carcinoma and its clinical significance
  71. Suppression of C-myc Expression Associates with Anti-Proliferation of Aloe-Emodin on Gastric Cancer Cells
  72. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
  73. Aloe-emodin induces in vitro G2/M arrest and alkaline phosphatase activation in human oral cancer KB cells
  74. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents
  75. Detecting Carcinoma Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Immunomagnetic Beads and RT-PCR
  76. Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin
  77. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells
  78. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction
  79. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers